Why is Windlas Biotech falling/rising?

As of 12-Sep, Windlas Biotech Ltd is currently priced at 999.35, reflecting a slight increase of 1.4 (0.14%). The stock has shown a positive trend over the last two days, gaining 0.58% during this period. However, it opened the day with a loss of 2.46%, touching an intraday low of Rs 973.4 before reaching a high of Rs 1024.5, indicating some volatility. The stock's performance over the past week is a gain of 1.17%, while it has outperformed the benchmark Sensex over the past month with a return of 4.49% compared to the Sensex's 2.08%. Despite these positive indicators, there has been a decline in investor participation, with delivery volume decreasing by 2.45% against the five-day average. The company maintains a low debt-to-equity ratio and has reported strong financial results, including record net sales and profits, which supports its valuation.
In the broader market context, Windlas Biotech's recent performance shows a mixed picture when compared to the Sensex. While the stock has outperformed the benchmark over the past month, it has underperformed year-to-date, with a decline of 3.30% compared to the Sensex's gain of 4.82%. The stock's long-term performance remains strong, with a significant return of 319.45% over the past three years, indicating consistent returns that have outperformed the BSE500 in each of the last three annual periods. This suggests that while short-term fluctuations may be occurring, the overall trend for Windlas Biotech remains positive in the context of its historical performance.